Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From OTC as reported by transfer agent. Useful source for OTC info.
https://www.otcmarkets.com/stock/UEEC/security
per TA, outstanding shares increased to 188,005,956 9/3/2020.
FYI O/S update posted today: 187,755,956. An increase of 7,627,500.
Question for those with FDA experience: Does the upcoming 1-yr anniversary of Study Completion present specific concern for stockholders?
Thanks, kettleman. Same to ya. Now all we need is a premarket approval
I bought this stock a couple years ago to finance a new motorcycle. After cleverly trading in and out I am now ready to place an order with a manufacturer. My question is: Can a 250 lb marine with a full beard pull up to the biker bar on one of these?
https://www.vespa.com/us_EN/vespa-models/gts.html
Go UEEC! (I want the heated seat)
Outstanding shares increased by 1,545,500 as of today.
https://www.otcmarkets.com/stock/UEEC/security
No problem trust, but when I piss you off remember to reply to someone else. LOL
Volume slightly lower today - LOL. Wonder if they got enough for the pump?
Some of us take honest handle choices very seriously!
TA back to updating Outstanding Shares daily. No change.
https://www.otcmarkets.com/stock/UEEC/security
AS/OS not updated today on OTC. Has been updated daily by Transfer Agent.
https://www.otcmarkets.com/stock/UEEC/security
May mean nothing but conspicuous by absence
Sorry - here's a link to SEC filing:
https://www.otcmarkets.com/filing/html?id=13914862&guid=p5CHUHAsne46Cth
What's up here? Sched 13G/A filed 2/13/20 (as of 12/31/19) EMA Financial(also previous filer): 264,129,733 shares. Today's volume: 5,765,043 so far. Interesting
Pink current iformation. Stop sign gone. O/S shares increased 125K 4/6
I don't see any new SEC filings so I'm guessing this is in consideration of
8-K filed 4/8
https://www.otcmarkets.com/stock/UEEC/disclosure
Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch.
An article we shareholders should find interesting:
WASHINGTON (Reuters) - Johnson & Johnson (JNJ.N) said on Friday it abandoned plans to buy Takeda Pharmaceutical’s surgical patch product TachoSil, citing regulatory issues.
Takeda (4502.T), Japan’s biggest drugmaker, announced the sale of TachoSil, a surgical patch to control bleeding, to Johnson & Johnson’s subsidiary Ethicon for $400 million last May.
“Ethicon and Takeda have mutually decided to terminate the TachoSil transaction, agreeing that it was the right decision given the regulators’ concerns,” a representative for Johnson & Johnson said in a statement.
The chairman of the Federal Trade Commission, Joseph Simons, said earlier on Friday there were potential regulatory issues about the deal because Johnson & Johnson sells Evarrest, the only other U.S.-approved fibrin sealant patch designed to stop bleeding during surgery.
https://www.reuters.com/article/us-tachosil-m-a-johnson-johnson/johnson-johnson-abandons-deal-for-takedas-tachosil-surgical-patch-idUSKCN21S1XG
Why do I picture Beplate in a Steve Urkel pose saying, "Did I do that?"
By memory, which is always suspect, I believe the total Maxim number was 4 million. As one of UEEC's litigations if this has been settled in court I assume it would qualify as a material event to be disclosed. Guess we'll have to wait and see.
Outstanding shares (as reported by TA) have recently dropped by 1.346 million. Anyone know why?
Not much meat on this bone, mostly just "We're still here."
United Health Products Issues Progress Report
9:00 AM ET 3/20/20 | BusinessWire
HENDERSON, Nev.--(BUSINESS WIRE)--March 20, 2020--
United Health Products, Inc. (OTC: UEEC) (UHP or the company) today announced that it is proceeding with its Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp(R). In this current difficult environment, UHP has been working continuously with the FDA to advance its application, and has been working towards commercialization in anticipation of FDA approval.
Separately, the company announced that it is progressing in its negotiations with well positioned candidates interested in acquisition of the company or partnerships that allow penetration into the surgical markets.
About United Health Products
United Health Products develops technology; manufactures and markets patented hemostatic products for the healthcare and wound care sectors. The product, HemoStyp, is derived from oxidized regenerated cellulose. HemoStyp is an all-natural product designed to control bleeding. UHP is focused on identifying new markets and applications for its products and expanding its current markets. UHP currently sells a suite of hemostatic products to the dental, veterinary and retail markets.
For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200320005101/en/
Today's volume only 776k vs average >5Mil. Stubborn stand off between wide spread with ask holding into close. Can this move up quickly when general market confidence improves? oh yeah.
SUNSTOCK, INC. ANNOUNCES NEW BUSINESS STRATEGY AND UPLIST EFFORT TO OTCQB
8:00 AM ET 3/16/20 | GlobeNewswire
SUNSTOCK, INC. ANNOUNCES NEW BUSINESS STRATEGY AND UPLIST EFFORT TO OTCQB
SACRAMENTO, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Sunstock, Inc. (OTC PINK: SSOK) announced that it has added to its existing precious metals sales and distribution strategy by targeting acquisitions in the gold mining industry. Concurrently, the company is working with its partners and advisors on a strategy to uplist to the OTCQB.
Jason Chang, Chief Executive Officer, stated, "We are excited to enter the mining industry and employ a complete "ground to coin" business strategy. We are looking for merger and acquisition candidates in the mining business as we organically grow our sales and distribution channels." Further, Jason stated "it makes sense for us to pursue an uplist to the OTCQB at this time, given the recent payoff of our debts, our consistent reporting history, and our future prospects."
ABOUT Sunstock, Inc.:
Sunstock, Inc. (OTC PINK: SSOK) is involved in mining and distribution of precious metals, primarily gold. The Company pursues a "ground to coin" strategy, whereby it secures and/or acquires mining assets as well as rights to purchase mining production, and sells these metals primarily through retail channels through their own branded coins.
CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.
Contact and further information:
Mr. Jason Chang, CEO
(916) 860-9622
Email: enquiry@sunstockinc.com
www.sunstockinc.com
> Dow Jones Newswires
March 16, 2020 08:00 ET (12:00 GMT)
I feel a little silly for not asking the definition of "very soon."
Thanks DR. Not sure if company will respond but this is the most sane and calm action this board has seen in a while. Stay well.
Wow ... 386,748 shares traded today. I wonder if TA will verify shares OS Monday. Have a great weekend ya'all!
UEEC down another 2%(was much lower intraday) today. Probably only person with worse day was Harvey Weinstein. I guess we both deserved it.
let me be sure I understand: You're saying management refrains from submitting financials and threatens reverse split because they want stock price "held down"? Doubtful, but if you say so ...
I'll have a double, please. Save's us both a repeat trip to the bar.
On days like today I find it helpful to remind myself ... tequila has only 69 calories/ounce
It will take a little time before very many people notice. BLDV hasn't been a highly watched hot stock. I believe should have a minor positive effect.
BLDV Merger with Harvest 360 Technologies Delivering on Financial and Operational Promises to Shareholders - Cannabis Business Model Leading the Way in Missouri, Puerto Rico and Illinois
Denver, Colorado--(Newsfile Corp. - February 24, 2020) - "The merger has delivered on the promised success," said Blue Diamond Ventures, Inc. (OTC Pink: BLDV) CEO, Josh Alper. We achieved over $1 million (US) in revenue for 2019 without adding any debt or selling any shares, and successfully completed the first of the tech partnerships that will continue to produce revenue."
Blue Diamond Ventures Inc. completed the acquisition of Harvest 360 Technologies LLC ("H360 '') in September of 2019, making H360 a 100% wholly owned subsidiary. This increased revenues and completed the transition of BLDV into a cannabis biotech company. This unique, first of its kind cannabis merger in the OTC Pinksheets sets the stage for rapid growth at BLDV. Recent events have proven this is a successful business model.
Harvest 360, a veteran-owned cannabis management firm, wrote a winning application in August 2019 in the laboratory round of licensing in Missouri. A decision on another three of their Missouri applications is pending. "H360 has made a commitment to safe and responsible cannabis products starting in Chillicothe, Missouri with Green Orchard Labs," says West Point graduate and 27-year Army veteran Todd Scattini, CEO of H360 and chairman of the BLDV board of directors. "We have agreed to a multi-year technology agreement with the owners in Missouri and will open the newly licensed cannabis testing effort, Green Orchard Labs under the name H360 Labs, Inc."
The promise of delivering positive patient outcomes - especially for veterans in Missouri - has been a major part of Todd's mission. It was the inspiration behind his efforts in the cannabis industry including the Athena Protocol, a patent pending non-impairing cannabinoid treatment for Chronic Traumatic Encephalopathy (CTE) and Traumatic Brain Injury (TBI).
H360 Labs Inc. is the name of the new, wholly owned subsidiary of BLDV, used for the new Industrial Hemp Testing Facility planned for San Juan, Puerto Rico. The lab in Puerto Rico will have a major R&D component and will work closely with the new Industrial Hemp Program being developed by the Dept of Agriculture in Puerto Rico. H360 Labs Inc. will begin with mobile field testing and farmer support starting in March 2020 which will lead to the construction of the establishment of the first permanent Industrial Hemp Testing lab on the island. "Ever since Hurricane Maria, we have been hyper-focused on Puerto Rico, with an aim to create serious business opportunities for the hemp and cannabis industry. PR has the ideal positioning to be a global nexus for the equatorial regions in our hemisphere. This region is prime to be the world's top supplier of low-cost hemp and cannabis products," says Navy Veteran and Puerto Rican native David Serrano, Chief of Business Development for Harvest 360. "By acquiring and deploying laboratory capabilities we are positioning to be a critical and mandatory fixture in the ecosystem. I anticipate more opportunities to come." Harvest 360 has engaged Porzio, Bromberg, and Newman attorney and former Secretary of State of Puerto Rico, Luis G. Rivera Marin, to meet all regulatory requirements and manage government relations on the Island.
According to Alper, Blue Diamond Ventures, Inc. is in the process of producing the investment documents that will raise just over $2 million (USD) for construction of the approved THC testing facility in Missouri and CBD-Industrial Hemp Lab in Puerto Rico. The offer will be structured as promissory notes that will give investors direct access to profits from these projects.
Application work in Illinois helped drive revenue in 2019, H360 hit the ground running submitting thirty cannabis operations applications on behalf of eight clients. These applications in Illinois will lead to new business development and technology agreements in the future. To help build out the license application division, Michelle Salser, a well-known and winning technical application writing specialist from California has been invited to become Applications Director for H360.
By all counts, the futures of BLDV and H360 are looking greener.
About BLDV
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52706
I would think a Bernie election would be a positive for Hemostyp. We would need a way to stop the hemorrhaging.
Thanks DR. You already know I respect your opinion & integrity. However, present company (which owns Hemostyp patent) putting effort and resources to a peer review clouds my perspective of the situation. If FDA approval is eminent as is also sale of the company (or Hemostyp which is basically the company) then what is the purpose of this maneuver?
Having a simple mind is a blessing and a curse.
Yeah Stonks - it applies, although I am not knowledgeable as to how much. Does the FDA approval we are awaiting depend on a peer review? To be honest, that has not been a factor to evaluate until today(for me.) I have become accustomed to being fat and ugly ... needing to add "even more ignorant than average" would piss me off.
Thank you for your reply. I do appreciate it.
"Assuming that it obtains peer review approval, the paper will be published and later presented at an upcoming medical conference."
Anyone have an educated guess as to how long peer review approval might take?
Thanks for the informative post but I would expect FDA approval sooner than I would expect this process to mature. Am I missing something here?
Margarita time ... Have a great weekend, ya'll.
My crazy low standing buy order may be triggered today. Thank you.
Thanks for your input DR. It is appreciated.
Good to see you DR. I am also anxiously awaiting approval - hope you are correct. As far as the other I have a gorgeous CPA with an astounding amortization table so self-depreciation is never necessary.
If you're going to take a taxi for some celebratory bourbon in Harlan County, be careful. It gets rough down there. I may open a bottle of the Macallan, myself.
Good luck to all the longs. $UEEC